Back

Discussant review - VICTORION-Difference

30 August 2025 (17:10 - 17:13)
Organised by: Logo
Congress Presentation Part of: HOT LINE 4 Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail
BaxHTN – Efficacy and safety of the aldosterone synthase inhibitor baxdrostat in patients with uncontrolled or resistant hypertension
Professor B. Williams (London, GB)
Slides Video
Presentation thumbnail
Discussant review - BaxHTN
Professor T. Guzik (Edinburgh, GB)
Slides Video
Presentation thumbnail
Panel discussion - BaxHTN
Presentation thumbnail
KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk
Doctor N. Pagidipati (Durham, US)
Slides Video
Presentation thumbnail
Discussant review - KARDIA-3
Professor M. Tomaszewski (Manchester, GB)
Slides Video

Access the full session

Session thumbnail
HOT LINE 4
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 17:10 CET
You may be interested in
thumbnail
Congress Session
Ask the Trialists - VICTORION
30 August 2025
thumbnail
Congress Presentation
High individual variability in LDL-reductions after inclisiran administration in a "real-world setting"
26 August 2022
thumbnail
Congress Presentation
Lipid goal attainment across baseline socioeconomic and clinical factors comparing an "inclisiran first" implementation strategy and usual care: subgroup analysis of VICTORION-INITIATE
30 August 2024
thumbnail
Congress Presentation
New treatment options for LDL cholesterol.
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources